Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Health impact and cost of COVID-19 prophylaxis with monoclonal antibodies

View ORCID ProfileAbraham D. Flaxman, View ORCID ProfileRodal Issema, View ORCID ProfileRuanne V. Barnabas, View ORCID ProfileJennifer M. Ross
doi: https://doi.org/10.1101/2021.08.31.21262923
Abraham D. Flaxman
1Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Abraham D. Flaxman
Rodal Issema
2Department of Epidemiology, University of Washington, Seattle, WA
3International Clinical Research Center, Department of Global Health, University of Washington, Seattle, WA
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rodal Issema
Ruanne V. Barnabas
2Department of Epidemiology, University of Washington, Seattle, WA
3International Clinical Research Center, Department of Global Health, University of Washington, Seattle, WA
4Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA
MBChB
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ruanne V. Barnabas
Jennifer M. Ross
3International Clinical Research Center, Department of Global Health, University of Washington, Seattle, WA
4Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jennifer M. Ross
  • For correspondence: jross3{at}uw.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Article usage

Article usage: September 2021 to August 2025

AbstractFullPdf
Sep 20211723121213
Oct 20211993278
Nov 20211351450
Dec 2021711013
Jan 202246189
Feb 202239911
Mar 2022731118
Apr 202248711
May 20225389
Jun 20223946
Jul 20224017
Aug 20223523
Sep 202237311
Oct 20223517
Nov 20222314
Dec 20222215
Jan 202325310
Feb 20232136
Mar 20231414
Apr 202333117
May 202312310
Jun 20231167
Jul 20231125
Aug 202319138
Sep 20231744
Oct 20231212
Nov 202322115
Dec 20231201
Jan 20241501
Feb 20241552
Mar 2024756
Apr 2024725
May 2024635
Jun 20241103
Jul 2024836
Aug 20241665
Sep 20242919
Oct 20241365
Nov 20242217
Dec 20241249
Jan 20251714
Feb 202518205
Mar 202529239
Apr 202524010
May 202529169
Jun 202528127
Jul 2025332326
Aug 2025220
Back to top
PreviousNext
Posted September 01, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Health impact and cost of COVID-19 prophylaxis with monoclonal antibodies
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Health impact and cost of COVID-19 prophylaxis with monoclonal antibodies
Abraham D. Flaxman, Rodal Issema, Ruanne V. Barnabas, Jennifer M. Ross
medRxiv 2021.08.31.21262923; doi: https://doi.org/10.1101/2021.08.31.21262923
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Health impact and cost of COVID-19 prophylaxis with monoclonal antibodies
Abraham D. Flaxman, Rodal Issema, Ruanne V. Barnabas, Jennifer M. Ross
medRxiv 2021.08.31.21262923; doi: https://doi.org/10.1101/2021.08.31.21262923

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)